All News

Big pharma is hungry, and is paying biotechs breathtaking prices to fill its pipelines. This made for a heady atmosphere at BioEurope in Düsseldorf this week.

A national network of 22 nanotechnology centres across the UK was formally launched last week with £50 million in government funding.

The head of Microsoft’s Cambridge lab outlines the strategy: to scout the science world for new software markets.

QinetiQ is leading a new consortium from industry, academia and the "UK defence supply chain" for MEMs Applications for Defence.

This time it is a major drugs company that is setting up its fume cupboards in China.

Do you qualify for R&D Tax Credits? The Treasury offers advice for companies that spend on R&D in the UK.

Seven universities in Texas are to get $1.4 million from the US Department of Defense.

In my August 16 blog, I discussed the European challenge to Google Library project. I was sceptical about the chances of its success. Recent declarations of the French National Library director, Jean-Noel Jeanneney, the main promoter of the project, only reinforce my scepticism. According to Mr. Jeanneney, the project will be most probably called Europeana, to reflect its Greek-Latin lineage.

On October 22, Japan’s Supreme Court struck a blow for employees of major corporations, who make valuable inventions.

For the first time biotechnology has overtaken software as the US venture capitalists’ darling, according to the quarterly MoneyTree Report published by PricewaterhouseCoopers last week.

Cambridge Enterprise’s new director vows flexibility as she enforces a controversial new campus policy on intellectual property.